VEGFA and age-related macular degeneration: Pegaptanib, an aptamer specific for vascular endothelial growth factor (VEGF), was licensed in 2000 as Macugen® by OSI Pharmaceuticals for age-related macular degeneration treatment (Ng and Adamis, 2006).